Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

IJTLD open

Showing results (161-170 of 296) with videos related to

Pageof 30
Sort By:
IJTLD Open|January 19, 2026
Treatment and outcomes in patients with non-TB mycobacterial pulmonary disease: a single-centre studyV N Dahl, A Fløe, F Rudolf, et al.
IJTLD Open|March 17, 2025
Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatmentS E Purchase, J Brigden, J A Seddon, et al.
IJTLD Open|March 17, 2025
An open-label cluster-randomised trial on TB preventive therapy for childrenG Lemvik, L Larsson, F Rudolf, et al.
IJTLD Open|July 22, 2024
Screening rates for HIV and diabetes in patients with active TB: results of a nationwide survey in JapanY Kimura, Y Sasabuchi, T Jo, et al.
IJTLD Open|September 17, 2025
Bedaquiline and levofloxacin replacing rifampicin for the treatment of TBC-Y Chiang, K-J Bai, M-C Yu
IJTLD Open|December 15, 2025
HIV status is linked to higher odds of persistent respiratory symptoms in Tanzania: a longitudinal analysisJ S Kreniske, G Ruselu, S Zhang, et al.
IJTLD Open|April 14, 2025
Incremental yield in detection of TB by testing multiple stool specimens from one personE Tiemersma, B Yenew, G Diriba, et al.
IJTLD Open|July 14, 2025
Underutilisation of GeneXpert devices for TB diagnosis: a missed opportunityJ Dörfler, O G Ravololohanitra, T Decroo, et al.
IJTLD Open|November 17, 2025
Optimising child-friendly TB preventive treatment regimensC Mulder, A J Bergman, F Mulatu, et al.
IJTLD Open|November 17, 2025
Comparing end-user diagnostic outputs from a commercial tNGS pipeline for <i>Mycobacterium tuberculosis</i> drug resistance detectionM Seifert, R E Colman, S Laurent, et al.
Pageof 30

Showing results (161-170 of 296) with videos related to

Sort By:
Pageof 30
IJTLD Open|January 19, 2026
Treatment and outcomes in patients with non-TB mycobacterial pulmonary disease: a single-centre studyV N Dahl, A Fløe, F Rudolf, et al.
IJTLD Open|March 17, 2025
Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatmentS E Purchase, J Brigden, J A Seddon, et al.
IJTLD Open|March 17, 2025
An open-label cluster-randomised trial on TB preventive therapy for childrenG Lemvik, L Larsson, F Rudolf, et al.
IJTLD Open|July 22, 2024
Screening rates for HIV and diabetes in patients with active TB: results of a nationwide survey in JapanY Kimura, Y Sasabuchi, T Jo, et al.
IJTLD Open|September 17, 2025
Bedaquiline and levofloxacin replacing rifampicin for the treatment of TBC-Y Chiang, K-J Bai, M-C Yu
IJTLD Open|December 15, 2025
HIV status is linked to higher odds of persistent respiratory symptoms in Tanzania: a longitudinal analysisJ S Kreniske, G Ruselu, S Zhang, et al.
IJTLD Open|April 14, 2025
Incremental yield in detection of TB by testing multiple stool specimens from one personE Tiemersma, B Yenew, G Diriba, et al.
IJTLD Open|July 14, 2025
Underutilisation of GeneXpert devices for TB diagnosis: a missed opportunityJ Dörfler, O G Ravololohanitra, T Decroo, et al.
IJTLD Open|November 17, 2025
Optimising child-friendly TB preventive treatment regimensC Mulder, A J Bergman, F Mulatu, et al.
IJTLD Open|November 17, 2025
Comparing end-user diagnostic outputs from a commercial tNGS pipeline for <i>Mycobacterium tuberculosis</i> drug resistance detectionM Seifert, R E Colman, S Laurent, et al.
Pageof 30